{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:24:59Z","timestamp":1789075499430,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10637-010-9594-0","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T11:36:16Z","timestamp":1291116976000},"page":"529-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines"],"prefix":"10.1007","volume":"30","author":[{"given":"Miguel","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cove\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,1]]},"reference":[{"key":"9594_CR1","volume-title":"SEER cancer statistics review, 1973\u20131996","author":"LA Ries","year":"1999","unstructured":"Ries LA, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (1999) SEER cancer statistics review, 1973\u20131996. National Cancer Institute, Bethesda"},{"key":"9594_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350:1535\u20131548","journal-title":"N Engl J Med"},{"key":"9594_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2174\/092986710790416308","volume":"17","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M, Cove\u00f1as R (2010) A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem 17:504\u2013513","journal-title":"Curr Med Chem"},{"key":"9594_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0026-2862(90)90024-L","volume":"40","author":"M Ziche","year":"1990","unstructured":"Ziche M, Morbidelli L, Pacini M, Gepetti P, Alessandri G, Maggi CA (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvas Res 40:264\u2013278","journal-title":"Microvas Res"},{"key":"9594_CR5","first-page":"4983","volume":"56","author":"W Luo","year":"1996","unstructured":"Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signalling pathway. Cancer Res 56:4983\u20134991","journal-title":"Cancer Res"},{"key":"9594_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.npep.2005.03.004","volume":"39","author":"M Mu\u00f1oz","year":"2005","unstructured":"Mu\u00f1oz M, Rosso M, P\u00e9rez A, Cove\u00f1as R, Zamarriego C, Piruat JI (2005) The NK1 receptor is involved in the antitumoural action of L-733, 060 and the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides 39:427\u2013432","journal-title":"Neuropeptides"},{"key":"9594_CR7","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1167\/iovs.04-1530","volume":"46","author":"M Mu\u00f1oz","year":"2005","unstructured":"Mu\u00f1oz M, Rosso M, P\u00e9rez A, Cove\u00f1as R, Rosso R, Zamarriego C, Soult JA, Montero I (2005) Antitumoral action of the neurokinin-1-receptor antagonist L-733, 060 and mitogenic action of substance P on human retinoblastoma cell lines. Invest Ophthalmol Vis Sci 46:2567\u20132570","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9594_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/157018006777574168","volume":"3","author":"M Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz M, Rosso M, Cove\u00f1as R (2006) The NK-1 receptor is involved in the antitumoural action of L-733, 060 and in the mitogenic action of substance P on human pancreatic cancer cell lines. Lett Drug Des Discovery 3:323\u2013329","journal-title":"Lett Drug Des Discovery"},{"key":"9594_CR9","first-page":"45","volume-title":"Brain cancer: therapy and surgical intervention","author":"M Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz M, Rosso M, Soult JA, Cove\u00f1as R (2006) Antitumoural action of neurokinin-1 receptor antagonists on human brain cancer cell lines. In: Yang AV (ed) Brain cancer: therapy and surgical intervention. Nova Science, New York, pp 45\u201375"},{"key":"9594_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10637-007-9087-y","volume":"26","author":"M Mu\u00f1oz","year":"2008","unstructured":"Mu\u00f1oz M, Rosso M, Aguilar FJ, Gonz\u00e1lez-Moles MA, Redondo M, Esteban F (2008) NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Invest New Drugs 26:111\u2013118","journal-title":"Invest New Drugs"},{"key":"9594_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000152942","volume":"29","author":"M Rosso","year":"2008","unstructured":"Rosso M, Robles-Fr\u00edas MJ, Cove\u00f1as R, Salinas-Mart\u00edn MV, Mu\u00f1oz M (2008) The NK-1 receptor is involved in the antitumor action of L-733, 060 and in the mitogenic action of substance P on human gastrointestinal cancer cell lines. Tumor Biol 29:245\u2013254","journal-title":"Tumor Biol"},{"key":"9594_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/cancers2020611","volume":"2","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M, Gonz\u00e1lez-Ortega A, Cove\u00f1as R (2010) The NK-1 receptor antagonist L-732, 138 induces apoptosis and counteracts substance P-related mitogenesis in human melanoma cell lines. Cancers 2:611\u2013623","journal-title":"Cancers"},{"key":"9594_CR13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/blood.V86.2.482.bloodjournal862482","volume":"86","author":"P Rameshwar","year":"1995","unstructured":"Rameshwar P, Gasc\u00f3n P (1995) Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86:482\u2013490","journal-title":"Blood"},{"key":"9594_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F (2004) Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112:231\u2013238","journal-title":"Int J Cancer"},{"key":"9594_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ijc.2910610608","volume":"61","author":"IM Hennig","year":"1995","unstructured":"Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61:786\u2013792","journal-title":"Int J Cancer"},{"key":"9594_CR16","first-page":"1388","volume":"97","author":"D Singh","year":"2000","unstructured":"Singh D, Joshi DD, Hameed M, Qian J, Gasc\u00f3n P, Maloof PB, Mosenthal A, Rameshwar P (2000) Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: Implications for bone marrow metastasis. Proc Natl Acad Sci USA 97:1388\u20131393","journal-title":"Proc Natl Acad Sci USA"},{"key":"9594_CR17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.LAB.0000067499.57309.F6","volume":"83","author":"H Friess","year":"2003","unstructured":"Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A, Reubi JC, Buchler MW (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Invest 83:731\u2013742","journal-title":"Lab Invest"},{"key":"9594_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2559.2008.03193.x","volume":"54","author":"F Esteban","year":"2009","unstructured":"Esteban F, Gonz\u00e1lez-Moles MA, Castro D, Mart\u00edn-Ja\u00e9n MDM, Redondo M, Ruiz-Avila I, Mu\u00f1oz M (2009) Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. Histopathology 54:258\u2013260","journal-title":"Histopathology"},{"key":"9594_CR19","first-page":"157","volume-title":"Focus on eye neoplasma research progress","author":"M Mu\u00f1oz","year":"2008","unstructured":"Mu\u00f1oz M, Rosso M, Robles-Fr\u00edas MJ, Cove\u00f1as R, Salinas-Mart\u00edn MV (2008) Immunolocalization of the neurokinin-1 receptor: a new target in the treatment of the human primary retinoblastoma. In: Bospene EB (ed) Focus on eye neoplasma research progress. Nova Science, New York, pp 157\u2013178"},{"key":"9594_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/labinvest.2010.92","volume":"90","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M, Robles-Fr\u00edas MJ, Salinas-Mart\u00edn MV, Cove\u00f1as R (2010) The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines. Lab Invest 90:1259\u20131269","journal-title":"Lab Invest"},{"key":"9594_CR21","doi-asserted-by":"crossref","first-page":"14321","DOI":"10.1016\/S0021-9258(18)67021-8","volume":"261","author":"DG Payan","year":"1986","unstructured":"Payan DG, McGillis JP, Organist ML (1986) Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. J Biol Chem 261:14321\u201314329","journal-title":"J Biol Chem"},{"key":"9594_CR22","first-page":"33","volume":"41","author":"M Nowicki","year":"2003","unstructured":"Nowicki M, Miskowiak B, Ostalska-Nowicka D (2003) Detection of substance P and its mRNA in human blast cells in childhood lymphoblastic leukaemia using immunocytochemistry and in situ hybridisation. Folia Histochem Cytobiol 41:33\u201336","journal-title":"Folia Histochem Cytobiol"},{"key":"9594_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0960-894X(95)00009-I","volume":"5","author":"T Harrison","year":"1995","unstructured":"Harrison T, Owens AP, Willians BJ, Swain CJ, Baker R, Hutson PH, Sadowski S, Cascieri MA (1995) Piperidine-ether based hNK1 antagonists 2: investigation of the effect of N-substitution. Bioorg Med Chem Lett 5:209\u2013212","journal-title":"Bioorg Med Chem Lett"},{"key":"9594_CR24","first-page":"105","volume":"142","author":"M Mu\u00f1oz","year":"2004","unstructured":"Mu\u00f1oz M, P\u00e9rez A, Cove\u00f1as R, Rosso M, Castro E (2004) Antitumoural action of L-733, 060 on neuroblastoma and glioma cell lines. Arch Ital Biol 142:105\u2013112","journal-title":"Arch Ital Biol"},{"key":"9594_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/01.cmr.0000129376.22141.a3","volume":"14","author":"M Mu\u00f1oz","year":"2004","unstructured":"Mu\u00f1oz M, P\u00e9rez A, Rosso M, Zamarriego C, Rosso R (2004) Antitumoural action of NK1 receptor antagonist L-733, 060 on human melanoma cell lines. Melanoma Res 14:183\u2013188","journal-title":"Melanoma Res"},{"key":"9594_CR26","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1167\/iovs.05-1591","volume":"48","author":"M Mu\u00f1oz","year":"2007","unstructured":"Mu\u00f1oz M, Rosso M, Cove\u00f1as R, Montero I, Gonz\u00e1lez-Moles MA, Robles MJ (2007) Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonists, L-732, 138. Invest Ophthalmol Vis Sci 48:2775\u20132781","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9594_CR27","first-page":"31","volume-title":"Focus on neuroblastoma research","author":"M Mu\u00f1oz","year":"2007","unstructured":"Mu\u00f1oz M, Rosso M, Cove\u00f1as R (2007) NK-1 receptor antagonists as new anti-tumoural agents: action on human neuroblastoma cell lines. In: Fernandes JA (ed) Focus on neuroblastoma research. Nova Science, New York, pp 31\u201356"},{"key":"9594_CR28","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","volume":"281","author":"MS Kramer","year":"1998","unstructured":"Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-knowles E, Halle JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlsson EJ, Hargreaves RJ, Rupniak NM (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640\u20131645","journal-title":"Science"},{"key":"9594_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S0028-3908(99)00172-0","volume":"39","author":"FD Tattersall","year":"2000","unstructured":"Tattersall FD, Rycroft W, Cumberbatch M, Mason G, Tye S, Williamson DJ, Hale JJ, Mills SG, Finke PE, MacCoss M, Sadowski S, Ber E, Cascieri M, Hill RG, MacIntyre DE, Hargreaves RJ (2000) The novel NK-1 receptor antagonist MK-0869 (L-754, 030) and its water soluble phosphoryl prodrug, L-758, 298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology 39:652\u2013663","journal-title":"Neuropharmacology"},{"key":"9594_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10637-009-9218-8","volume":"28","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M (2010) The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Invest New Drugs 28:187\u2013193","journal-title":"Invest New Drugs"},{"key":"9594_CR31","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00001813-200511000-00007","volume":"16","author":"M Bigioni","year":"2005","unstructured":"Bigioni M, Benzo A, Irrissuto C, Maggi CA, Goso C (2005) Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231. Anticancer Drugs 16:1083\u20131089","journal-title":"Anticancer Drugs"},{"key":"9594_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/1097-0215(20001001)88:1<12::AID-IJC3>3.0.CO;2-T","volume":"88","author":"JR Conejo","year":"2000","unstructured":"Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H, B\u00fcchler MW (2000) Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer 88:12\u201320","journal-title":"Int J Cancer"},{"key":"9594_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(00)00436-X","volume":"91","author":"SV Shrikhande","year":"2001","unstructured":"Shrikhande SV, Friess H, di Mola FF, Tempia-Caliera A, Conejo Garcia JR, Zhu Z, Zimmermann A, B\u00fcchler MW (2001) NK-1 receptor gene expression is related to pain in chronic pancreatitis. Pain 91:209\u2013217","journal-title":"Pain"},{"key":"9594_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1158\/1535-7163.MCT-06-0729","volume":"6","author":"V Moneo","year":"2007","unstructured":"Moneo V, Serelde BG, Leal JFM, Blanco-Aparicio C, D\u00edaz-Uriarte R, Aracil M, Tercero JC, Jimeno J, Carnero A (2007) Levels of p27kip1 determine Aplidin sensitivity. Mol Cancer Ther 6:1310\u20131316","journal-title":"Mol Cancer Ther"},{"key":"9594_CR35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1006\/bbrc.1994.1374","volume":"199","author":"JG Reeve","year":"1994","unstructured":"Reeve JG, Bleehen NM (1994) [D-Arg1-D-Phe5, D-Trp7, 9, Leu11] Substance P induces apoptosis in lung cancer cell lines in vitro. Biochem Biophys Res Commun 199:1313\u20131319","journal-title":"Biochem Biophys Res Commun"},{"key":"9594_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10555-006-8161-9","volume":"25","author":"F Esteban","year":"2006","unstructured":"Esteban F, Mu\u00f1oz M, Gonz\u00e1lez-Moles MA, Rosso M (2006) A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev 25:137\u2013145","journal-title":"Cancer Metastasis Rev"},{"key":"9594_CR37","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1471-4159.2009.06032.x","volume":"109","author":"T Akazawa","year":"2009","unstructured":"Akazawa T, Kwatra KG, Goldsmith LE, RichardsonMD CEA, Sampson JH, Kwatra MM (2009) A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor- mediated apoptosis in glioblastomas. J Neurochem 109:1079\u20131086","journal-title":"J Neurochem"},{"key":"9594_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/1042819021000029777","volume":"44","author":"A Aguayo","year":"2003","unstructured":"Aguayo A, Giles F, Albitar M (2003) Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes. Leuk Lymphoma 44:213\u2013222","journal-title":"Leuk Lymphoma"},{"key":"9594_CR39","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1074\/jbc.M808825200","volume":"284","author":"J Meshki","year":"2009","unstructured":"Meshki J, Douglas SD, Lai JP, Schwartz L, Kilpatrick LE, Tuluc F (2009) Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho\/Rho-associated coiled-coil kinase-dependent mechanism. J Biol Chem 284:9280\u20139289","journal-title":"J Biol Chem"},{"key":"9594_CR40","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1083\/jcb.200802081","volume":"181","author":"OT Fackler","year":"2008","unstructured":"Fackler OT, Grosse R (2008) Cell motility through plasma membrane blebbing. J Cell Biol 181:879\u2013884","journal-title":"J Cell Biol"},{"key":"9594_CR41","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/sj.leu.2402920","volume":"17","author":"M Nowicki","year":"2003","unstructured":"Nowicki M, Miskowiak B (2003) Substance P - a potent risk factor in childhood lymphoblastic leukaemia. Leukemia 17:1096\u20131099","journal-title":"Leukemia"},{"key":"9594_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1054\/bjoc.1999.0946","volume":"82","author":"C Palma","year":"2000","unstructured":"Palma C, Bigioni M, Irrissuto C (2000) Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft. Br J Cancer 82:480\u2013487","journal-title":"Br J Cancer"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-010-9594-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9594-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:21:20Z","timestamp":1678558880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-010-9594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9594"],"URL":"https:\/\/doi.org\/10.1007\/s10637-010-9594-0","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,1]]},"assertion":[{"value":"17 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}